Skip to main content
  • CHRONOPHARMACOTHERAPY OF HYPERTENSION: TIME-DEPENDENT EFFECTS OF TREATMENT ON BLOOD PRESSURE

    { DOWNLOAD AS PDF }

    ABOUT AUHTORS:
    Suresh Rewar1*, Bansal BK1, Singh CJ2, Sharma AK2
    1Department of pharmaceutics, Arya College of Pharmacy, Jaipur, Rajasthan India
    2Department Of Pharmacology, Arya College of Pharmacy, Jaipur, Rajasthan India
    sureshrewar1990@gmail.com

    ABSTRACT
    Chronopharmaceutical drug delivery systems are gaining a lot of interest as they deliver the drug at the right site of action, right time and right amount, as per the pathophysiological needs of the diseases. These systems are basically time-controlled drug delivery systems in which the system controls the lag time independent of environmental factors like pH, enzymes, GIT motility, etc. These systems are designed for chronopharmacotherapy which is based on the circadian rhythm of the body. The effectiveness and toxicity of many drugs vary depending on dosing time associated with 24 hr. rhythms of biochemical, physiological and behavioral processes under the control of circadian clock. The chronobiology of the various common 24-hour BP profiles seen in hypertensive patients in relation to cardiovascular risk and end-organ injury and ultimately the control and normalization of abnormal BP throughout daytime activity and night time sleep. Chronopharmacotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease. Various latest and upcoming marketed technologies of Chronopharmaceutical drug delivery used in treatment of hypertension diseases like OROS®, CODAS®, CEFORM®, DIFFUCAPS®, PULSINCAP® etc.

  • A CASE STUDY ON HEMOLYTIC UREMIC SYNDROME- LEADING TO ACUTE RENAL FAILURE
    A CASE STUDY ON HEMOLYTIC UREMIC SYNDROME- LEADING TO ACUTE RENAL FAILURE

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Jiguru Prasant*, Mohammad Kaleemullah Quraishi, Amer Khan
    Department of Doctor of Pharmacy,
    Krishna Institute of Medical Sciences and Bharat Institute of Technology (Pharmacy),
    Hyderabad, Telangana, India
    Prashant7792@gmail.com

    ABSTRACT
    A 65 yrs female patient was presented with  complaints of vomiting,  loose stools, pain,  fever, high grade chills,  giddiness, loss of appetite acute renal failure, hemolytic anemia and thrombocytopenia She was diagnosed with Escherichia coli  associated hemolytic-uremic syndrome and treated with plasmapheresis and other medications for 3 weeks. She recovered without sequelae.

    [adsense:336x280:8701650588]

  • TARGETED DRUG DELIVERY SYSTEMS FOR LUNG CANCER
    TARGETED DRUG DELIVERY SYSTEMS FOR LUNG CANCER

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Abdul Waheed1*, Ankit Gupta2, Parth Patel3
    1Department of Pharmacology
    2Department of Pharmaceutics
    3Department of Drug Regulatory Affair
    Amity Institute of Pharmacy, Amity University, Noida-125, U.P. (INDIA)
    abdul.waheed2050@gmail.com

    ABSTRACT
    In the present scenario, lung cancer is one of the most prevalent and malignant cancer especially among the smoking group of people. The targeted delivery of chemotherapeutic agents to the lungs represents a novel therapeutic approach in lung cancer. Lung is an ideal route for administration of anticancer drug as it provides larger alveolar surface area, low thickness of epithelial barrier & extensive vascularization. Nanoparticles with nanocarriers have possibility of cell-targeted drug delivery with minimal systemic side effect and toxicity. Pulmonary epithelial cell, enzymes, receptors and genes are the target of the targeted drug delivery in lung cancer. This paper reviews the till date targeted drug delivery research performed for the treatment of lung cancer.

  • NEED AND APPLICATION OF ANALYTICAL METHOD DEVELOPMENT ON NEW FIXED DOSE COMBINATION OF IRBESARTAN AND ATORVASTATIN IN PHARMACEUTICAL INDUSTRY
    NEED AND APPLICATION OF ANALYTICAL METHOD DEVELOPMENT ON NEW FIXED DOSE COMBINATION OF IRBESARTAN AND ATORVASTATIN IN PHARMACEUTICAL INDUSTRY
  • REVIEW: PLAGIARISM AN ACT OF UNETHICS
    REVIEW: PLAGIARISM AN ACT OF UNETHICS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Anuradha Sharma1*, Vaibhav Walia2, Monika Gahlawat3
    1Division of Pharma. Chemistry, 2Division of Pharmacology, 3Division of Pharmaceutics,
    G.V.M. College of Pharmacy,
    Sonepat, Haryana, India
    *anusarswat@gmail.com

    ABSTRACT
    Plagiarism is a multifaceted and ethically a complex problemwhich simply means the stealing and publication of another author’s work as one's own original work without acknowledge the original author. Plagiarism is simply an act of fraud.Authors should acknowledge sources fully and appropriately to follow the ethics and plagiarism is failure to do so. However the students or the authors sometimes fail to acknowledge the source appropriately and properly. These failures are largely due to the lack of knowledge to use the citations properly. Therefore to maintain the ethics the plagiarism should be avoided. The aim of this paper is to define plagiarism, its type, methods of detection and the ways to avoid plagiarism.

  • A REVIEW ON PARKINSON’S DISEASE: ITS PATHOPHYSIOLOGY, TREATMENT AND SURGERY
    A REVIEW ON PARKINSON’S DISEASE: ITS PATHOPHYSIOLOGY, TREATMENT AND SURGERY

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Singh Divya1, Siddhi Shrimali2, Rathore KS2*
    1Department of Pharmacology, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
    2Department of Pharmaceutics, BN Institute of Pharmaceutical Sciences, Udaipur, Rajasthan, India
    *kamalsrathore@gmail.com

    ABSTRACT
    Parkinsonism disease (PD) is a progressive neurological disorder. Degeneration of dopamine producing cells in the substantia nigra (part of the basal ganglia) leads to a decreased dopamine production. The cause of the damage is unknown. The main known risk factor is age. Parkinson’s affects functional activities such as balance, walking, speech, handwriting, typing, fastening buttons, driving, and many other simple, or complex but familiar and routine activities, as they are usually controlled by the mechanisms of dopamine and the basal ganglia. This review briefly focuses on deep brain stimulation neurosurgical treatment. Levodopa was the first drug approved specifically for Parkinson’s disease. Levodopa is converted by enzymes in the brain to produce dopamine, thereby supplementing function that has been lost as dopamine-producing neurons die.Topics covered in the review includes pathogenesis, mechanism of action, side effects of medicines and neurological surgery.

  • MOLECULAR DOCKING STUDIES OF N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES WITH ANTI-DIABETIC ACTIVITY OF TYPE 2 DIABETES
    MOLECULAR DOCKING STUDIES OF N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES WITH ANTI-DIABETIC ACTIVITY OF TYPE 2 DIABETES

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Anuradha Sharma1*, Vaibhav Walia2, Monika Gahlawat3
    1Division of Pharma. Chemistry,2 Division of Pharmacology,3 Division of Pharmaceutics,
    G.V.M. College of Pharmacy,
    Sonepat, Haryana, India
    *anusarswat@gmail.com

    ABSTRACT
    Type 2 diabetes is one of the major life threatening diseases worldwide. These cases are progressing at an incremental rate every year and number of research works is going on to control the disease by targeting its enzymes or proteins. In modern drug designing, molecular docking is routinely used for understanding drug receptor interaction. In the present study molecular docking were performed on a diverse set of N-(2-benzoylphenyl)-L-tyrosine derivatives that demonstrate antidiabetic activity by stimulating peroxisome proliferator activated receptor- γ. The docking program in Glide dock justifies the correlation between the experimental values and the values derived computationally. Therefore, the dock analysis performed in Glide dock suggests the importance of evaluating the prediction accuracy of scoring functions adopted in various docking program.

    [adsense:336x280:8701650588]

  • SIMULTANEOUS ESTIMATION OF LINEZOLID AND CEFIXIME IN THEIR COMBINED DOSAGE FORM
    SIMULTANEOUS ESTIMATION OF LINEZOLID AND CEFIXIME IN THEIR COMBINED DOSAGE FORM

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Joshi HV*1, Patel JK2, Shah UA1, Patel Kinjal1
    1Department of QA,
    2Department of Pharmaceutics,
    Nootan Pharmacy College, Visnagar, Gujarat, India
    hirakjoshi@gmail.com

    ABSTRACT
    Simple, accurate, precise, reproducible, requiring no prior separation and economical procedures for simultaneous estimation of Linezolid (LIN) and Cefixime (CEF) in tablet dosage form have been developed. The method is simultaneous equation method; in this method 257.0 nm and 288.0 nm were selected respectively for LIN and CEF to measure the absorbance of both the drugs at mentioned wavelengths. Both the drugs show linearity at 10-50 μg/mL, the range was selected by studying their ratio present in combined formulation. Recovery studies range from >99.35% for CEF and >99.23% for LIN in mentioned analytical method i.e. simultaneous equation method. The proposed methods are recommended for routine analysis since it is rapid, simple, accurate and also sensitive and specific (no heating and no organic solvent extraction is required).

  • Natural Mysteries, yet to be tapped in Drug Discovery and Delivery
    Natural Mysteries, yet to be tapped in Drug Discovery and Delivery

    Editorial, Dec 2014 issue

    ““ Natural products may be obtained from terrestrial and marine plants, microorganism, vertebrates or invertebrates. Most of the times hint emanates from close observation, serendipity or accidental outcome.

  • DIFFERENCE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF ACEBUTOLOL HYDROCHLORIDE IN BULK AND IN ITS FORMULATION
    DIFFERENCE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF ACEBUTOLOL HYDROCHLORIDE IN BULK AND IN ITS FORMULATION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Jadhav Santosh*, Mali Audumbar, Pawar Seemarani, Kharat Rekha, Tamboli Ashpak
    Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade,
    Sangola-413307, Solapur, Maharashtra, India.
    *jadhavsan88@gmail.com

    ABSTRACT:
    A simple, precise and accurate difference spectroscopic method has been developed for the estimation of Acebutolol Hydrochloride in bulk drug form by difference spectrophotometric method. Acebutolol Hydrochloride has exhibited maximum absorbance at about 233nm and 234nm in acidic and basic solution respectively. Beer’s law was obeyed in the concentration range of 2-10 µg/ml in both the cases. The regression of coefficient was found to be r2=0.9992. The LOD and LOQ value were found to be 0.2670ppm and 0.8091ppm respectively. The proposed method was successfully applied for the determination of Acebutolol Hydrochloride in bulk drug. As per ICH guidelines the result of the analysis were validated statistically and were found to be satisfactory.

Subscribe to Articles